ProShare Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $171K | Sell |
36,723
-358
| -1% | -$1.67K | ﹤0.01% | 1761 |
|
|
2025
Q1 | $204K | Sell |
37,081
-9,472
| -20% | -$52K | ﹤0.01% | 1674 |
|
|
2024
Q4 | $158K | Sell |
46,553
-24,051
| -34% | -$81.5K | ﹤0.01% | 1956 |
|
|
2024
Q3 | $201K | Buy |
70,604
+43,630
| +162% | +$124K | ﹤0.01% | 1728 |
|
|
2024
Q2 | $60.7K | Sell |
26,974
-6,614
| -20% | -$14.9K | ﹤0.01% | 1722 |
|
|
2024
Q1 | $74.2K | Buy |
33,588
+2,739
| +9% | +$6.05K | ﹤0.01% | 1862 |
|
|
2023
Q4 | $72.5K | Buy |
30,849
+4,537
| +17% | +$10.7K | ﹤0.01% | 1818 |
|
|
2023
Q3 | $48.9K | Buy |
26,312
+122
| +0.5% | +$227 | ﹤0.01% | 1717 |
|
|
2023
Q2 | $68.6K | Buy |
26,190
+1,179
| +5% | +$3.09K | ﹤0.01% | 1742 |
|
|
2023
Q1 | $40.8K | Buy |
+25,011
| New | +$40.8K | ﹤0.01% | 1686 |
|
|
2022
Q4 | – | Sell |
-26,029
| Closed | -$41K | – | 1894 |
|
|
2022
Q3 | $41K | Buy |
26,029
+601
| +2% | +$947 | ﹤0.01% | 1678 |
|
|
2022
Q2 | $39K | Buy |
25,428
+11,445
| +82% | +$17.6K | ﹤0.01% | 1731 |
|
|
2022
Q1 | $36K | Sell |
13,983
-3,578
| -20% | -$9.21K | ﹤0.01% | 2140 |
|
|
2021
Q4 | $51K | Buy |
17,561
+3,356
| +24% | +$9.75K | ﹤0.01% | 2283 |
|
|
2021
Q3 | $35K | Buy |
14,205
+2,280
| +19% | +$5.62K | ﹤0.01% | 1986 |
|
|
2021
Q2 | $49K | Sell |
11,925
-8,539
| -42% | -$35.1K | ﹤0.01% | 2359 |
|
|
2021
Q1 | $92K | Buy |
20,464
+2,723
| +15% | +$12.2K | ﹤0.01% | 2176 |
|
|
2020
Q4 | $87K | Buy |
17,741
+4,651
| +36% | +$22.8K | ﹤0.01% | 2006 |
|
|
2020
Q3 | $78K | Buy |
13,090
+2,010
| +18% | +$12K | ﹤0.01% | 1551 |
|
|
2020
Q2 | $29K | Buy |
+11,080
| New | +$29K | ﹤0.01% | 1647 |
|
|
2019
Q4 | – | Sell |
-10,344
| Closed | -$102K | – | 1804 |
|
|
2019
Q3 | $102K | Buy |
10,344
+314
| +3% | +$3.1K | ﹤0.01% | 1546 |
|
|
2019
Q2 | $115K | Sell |
10,030
-1,291
| -11% | -$14.8K | ﹤0.01% | 1517 |
|
|
2019
Q1 | $114K | Buy |
+11,321
| New | +$114K | ﹤0.01% | 1559 |
|